Iranian Journal of Neurology 2017. 16(1):34-40.

Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasons
Mohammad Ali Sahraian, Mohammad Sahebkar, Rouhollah Dehghani, Milad Derakhshan-Jazari, Vahid Kazami-Moghaddam, Ebrahim Kouchaki


There has been a global rising trend in recent years in the incidence of multiple sclerosis (MS). Despite being an MS low-risk region, this disease has also been recently on the rise in the Middle East. As part of the Middle East, Iran has not been spared either; however, the cause of this dramatic increase remains to be discovered. This study reviews possible reasons for this increase in Iran. Although many factors such as the increased rate of smoking, lifestyle changes, modernization, and contact with toxic solvents can be proposed as reasons for this sudden rise in the prevalence of MS in Iran, these factors cannot be taken as definite causes and further studies are required to prove their impact.


Multiple Sclerosis; Causality; Prevalence; Incidence; Environmental Factors; Iran

Full Text:



Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008; 31(4):325-30.

Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007; 29(1): 1-9.

Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007;61(6): 504-13.

Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33(1): 3-11.

Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity--friends or foes? Trends Immunol 2009; 30(8): 409-14.

Sumelahti ML, Hakama M, Elovaara I, Pukkala E. Causes of death among patients with multiple sclerosis. Mult Scler 2010; 16(12): 1437-42.

Baghizadeh S, Sahraian MA, Beladimoghadam N. Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Iran J Neurol 2013; 12(1): 1-8.

Ramsaransing GS, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand 2006; 113(6): 359-69.

National Multiple Sclerosis Society.Multiple Sclerosis Information Sourcebook. New York, NY: Information Resource Center and Library of the National Multiple Sclerosis Society; 2003.

Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow- up. Brain 1993; 116 (Pt 1): 117-34.

Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112 (Pt 1): 133-46.

Azimian M, Shahvarughi-Farahani A, Rahgozar M, Etemadifar M, Nasr Z. Fatigue, depression, and physical impairment in multiple sclerosis. Iran J Neurol 2014; 13(2): 105-7.

Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004; 3(12): 709-18.

Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg 2012; 112(4): 327-33.

Sahraian MA, Pakdaman H, Harandi AA.Is it time to revise the classification of geographical distribution of multiple sclerosis? Iran J Neurol 2012; 11(2):77-8.

Elhami SR, Mohammad K, Sahraian MA, Eftekhar H. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36(3): 141-7.

World Health Organization. Atlas multiple sclerosis resources in the world 2008. Geneva, Switzerland: WHO; 2016.

Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, et al. Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries. Mult Scler Int 2013; 2013: 952321.

Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci 2011; 121(7):393-8.

Al-Hashel J, Besterman AD, Wolfson C.The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology 2008; 31(2): 129-37.

Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P. Multiple sclerosis in the Arabian Gulf countries: a consensus statement. J Neurol 2013; 260(12): 2959-63.

Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005; 234(1-2):67-71.

Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. Clinical characteristics of multiplesclerosis in Lebanon. J Neurol Sci 2008;270(1-2): 88-93.

El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y. Multiple sclerosis in Jordan: A clinical and epidemiological study. J Neurol2006; 253(9): 1210-6.

Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Prevalence and pattern of multiple sclerosis in Benghazi, north-eastern Libya. J Neurol Sci 1985;70(1): 39-46.

Tharakan JJ, Chand RP, Jacob PC.Multiplesclerosis in Oman. Neurosciences (Riyadh) 2005; 10(3):223-5.

Attia Romdhane N, Ben Hamda M, Mrabet A, Larnaout A, Samoud S, Ben Hamda A, et al. Prevalence study of neurologic disorders in Kelibia (Tunisia). Neuroepidemiology 1993; 12(5): 285-99.

Dehghani R, Yunesian M, Sahraian MA,Gilasi HR, Kazemi M, V. The evaluation of multiple sclerosis dispersal in Iran and its association with urbanization, life style and industry. Iran J Public Health 2015;44(6): 830-8.

Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Hamidian JA, Aghighi M, et al. Significant increase in the prevalence of multiple sclerosis in Iran in2011. Iran J Med Sci 2014; 39(2): 152-3.

Rezaali S, Khalilnezhad A, Naser MA, Chaibakhsh S, Sahraian MA. Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iran JNeurol 2013; 12(4): 136-43.

Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010; 64(6): 331-6.

Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg2013; 115(3): 304-8.

Etemadifar M, Abtahi SH. Multiple sclerosis in Isfahan, Iran: Past, present and future. Int J Prev Med 2012; 3(5):301-2.

Tunstall-Pedoe H. Preventing chronic diseases. A vital investment: WHO Global Report. Geneva, Switzerland: World Health Organization; 2005.

Buckley L, Bushart S, Efremenkov V, Karlin Y, Kohout R, Pabby A, et al. Application of membrane technologies for liquid radioactive waste processing (Technical Reports Series No. 431). Vienna, Austria: International Atomic Energy Agency; 2004. p. 145.

Ghassemi H, Harrison G, Mohammad K.An accelerated nutrition transition in Iran. Public Health Nutr 2002; 5(1A): 149-55.

Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, et al. Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology 2006;27(4): 212-6.

Dehghani R, Zarghi I, Hajijafari T, Falahnia M, Hosseni M. Investigation into level of iodine in Market iodized salt in Kashan, 2010. J North Khorasan Univ Med Sci 2013; 5(3): 593-600. [In Persian].

Harandi AA, Harandi AA, Pakdaman H,Sahraian MA. Vitamin D and multiple sclerosis. Iran J Neurol 2014; 13(1): 1-6.

Kazemi Saleh D, Jozani Z, Assar O,Lotfian I. The effect of vitamin D deficiency on coronary artery stenosis severity in angioplasty patients in Baqiatallah Hospital in 2013. J Arak Univ Med Sci 2014; 16 (10): 70-5. [In Persian].

Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009; 8(7): 621-6.

Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.

Fields J, Trivedi NJ, Horton E,Mechanick JI. Vitamin D in the Persian Gulf: integrative physiology and socioeconomic factors. Curr Osteoporos Rep 2011; 9(4): 243-50.

Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL. Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr 2001; 90(5): 577-9.

Dehghani R, Takht Firozeh M, Yeganeh M, Meghdadi M, Mosavi G, Haji Bagheri A, et al . Cigarette smoking status in the city of Ardestan City during 2010. J Ilam Univ Med Sci 2013; 21 (4): 75-82. [In Persian].

Dehghani R, Yunesian M, Sahraian M, Gilasi H, Danesh Pazhooh F, Kazemi Moghaddam V. The relationship between lifestyle and prevalence of multiple sclerosis in Iran: An Ecological Study in 2011. Community Health 2014; 8 (1):63-72. [In Persian].

Riise T, Nortvedt MW, Ascherio A.Smoking is a risk factor for multiple sclerosis. Neurology 2003; 61(8): 1122-4.

Maghzi AH, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, Khorvash F, et al. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: apopulation-based study. Mult Scler 2010;16(3): 359-61.

Rubin DH, Krasilnikoff PA, Leventhal JM, Weile B, Berget A. Effect of passive smoking on birth-weight. Lancet 1986;2(8504): 415-7.

Sundstrom P, Nystrom L, Hallmans G.Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 2008;15(6): 579-83.

Non-Communicable Disease Risk Factor InfoBase. Percentage who smoke tobacco daily - CI 95% - by different provinces- age and sex groups - Iran 2009 [Online]. [cited 2009]; Available from: URL: king Provincial tables__2009.pdf

Rabbani D, Mostafaii GR, Dehghani R, Gilasi H, Hosein Abadi Z. Evaluation of heavy metals in Iranian and Non-Iranianrice supplied by shopping centers of Kashan, Iran. International Archives of Health Sciences 2015; 2(1): 25-9.

Kelishadi R, Poursafa P. Air pollution and non-respiratory health hazards for children. Arch Med Sci 2010; 6(4):483-95.

Gregory AC, Shendell DG, Okosun IS, Gieseker KE. Multiple sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci Total Environ 2008; 396(1): 42-51.

Heydarpour P, Amini H, Khoshkish S,Seidkhani H, Sahraian MA, Yunesian M. Potential impact of air pollution on multiple sclerosis in Tehran, Iran. Neuroepidemiology 2014; 43(3-4): 233-8.

Talebi S, Tavakoli-Ghinani T. Levels of PM10 and its chemical composition in the atmosphere of the city of Isfahan. Iran J Chem Eng 2008; 5(3): 62-7.

Halek F, Kavouci A, Montehaie H. Role of motor-vehicles and trend of air borne particulate in the Great Tehran area, Iran.Int J Environ Health Res 2004; 14(4):307-13.

Dehghani R, Takhtfiroozeh S, Hosseindoost G, Mossayebi M, Arabfard M. Investigation the air quality city of Kashan during 2012 based on the air quality index. Armaghane-Danesh 2014;19 (4): 314-25. [In Persian].

Dehghani R. Human, environment and disease. Tehran, Iran: Farmanesh Publications; 2014. p. 1-485. [In Persian

].60. Bolviken B, Celius EG, Nilsen R, StrandT. Radon: a possible risk factor in multiple sclerosis. Neuroepidemiology2003; 22(1): 87-94.

Dehghani R, Fathabadi N, Kardan M,Mohammadi M, Atoof F. Survey of gamma dose and radon exhalation rate from soil surface of high background natural radiation areas in Ramsar, Iran. Zahedan J Res Med Sci 2013; 15(9): 81-4.

Fathabadi N, Mohammadi M, Dehghani R, Kardan M, Atoof F, Vashghani Farahani M, et al. The effects of environmental parameters on the radon exhalation rate from the ground surface in HBRA in Ramsar with a regression model. Life Sci J 2013; 10(5s): 563-9.

Riise T, Moen BE, Kyvik KR. Organic solvents and the risk of multiple sclerosis. Epidemiology 2002; 13(6): 718-20.

Mortensen JT, Bronnum-Hansen H, Rasmussen K. Multiple sclerosis and organic solvents. Epidemiology 1998;9(2): 168-71.

Koch MW, Metz LM, Agrawal SM, Yong VW. Environmental factors and their regulation of immunity in multiple sclerosis.J Neurol Sci 2013; 324(1-2): 10-6.

Dehghani R. Environmental toxicology. 1st ed. Tehran, Iran: Takderakht Publications; 2010. [In Persian].

Dehghani R, Shayeghi M, Esalmi H, Mosavi GA, Rabani DK, Hossein Shahi D Detrmination of organophosphorus pesticides (diazinon and chlorpyrifos) in water resources in Barzok, Kashan. Zahedan J Res Med Sci 2012; 14(10):66-72.

Dehghani R, Sabahi Bidgoli M, Asgari Arani J, Rashedi Vahed G, Heydari F, Soheili Z, et al. A Survey on the application and storage conditions of pesticides in Kashan, Iran, 2012. Iran Occup Health 2013; 2(1-2).

Dehghani R, Limoee M, Zarghi I. The review of pesticide hazards with emphasis on insecticide resistance in arthropods of health risk importance. SciJ Kurdistan Univ Med Sci 2012; 17(1):82-98. [In Persian].

Dehghani R, Moosavi S, Esalmi H, Mohammadi M, Jalali Z, Zamini N. Surveying of pesticides commonly on themarkets of Iran in 2009. J Environ Prot2011; 2(8): 1113-7.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.